Clinical trial
A Study of Ritonavir (ABT-538) When Used With Nelfinavir in HIV-Infected…
NCT00002201 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00002201 |
|---|---|
| Title | A Study of Ritonavir (ABT-538) When Used With Nelfinavir in HIV-Infected Patients |
| Official title | Safety and Efficacy of Ritonavir (ABT-538) in Combination With Nelfinavir in HIV-Infected Subjects. |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Ritonavir, Nelfinavir mesylate |
| First posted | Aug 31, 2001 |
| Last update posted | Feb 20, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: